Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review

by Locke D. Uppendahl, Carly M. Dahl, Jeffrey S. Miller, Martin Felices, Melissa A. Geller
Published 2018-01-01

Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation

by Hemant K. Mishra, Kate J. Dixon, Nabendu Pore, Martin Felices, Jeffrey S. Miller, Bruce Walcheck
Published 2021-07-01

470 Targeting Pan-Tumor Associated Antigen B7H3 via Combination of Tri-specific Killer Engager and Off-the-shelf NK Cell Therapy Enhances Specificity and Function Against a Broad R...

by Joshua Walker, Nicholas Zorko, Behiye Kodal, Alexander Lenvik, Todd Lenvik, Daniel Vallera, Alejandro Garcia, Martin Felices
Published 2020-11-01

Therapeutic effect of TRC105 and decitabine combination in AML xenografts

by June Baik, Martin Felices, Ashley Yingst, Charles P. Theuer, Michael R. Verneris, Jeffrey S. Miller, Rita Perlingeiro
Published 2020-10-01

A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer

by Daniel A. Vallera, Felix Oh, Behiye Kodal, Peter Hinderlie, Melissa A. Geller, Jeffrey S. Miller, Martin Felices
Published 2021-08-01

675 Oxygen concentration alters natural killer cell phenotype and function in the solid tumor microenvironment

by Martin Felices, Upasana Sunil Arvindam, Phillipa Kennedy, Brianna Ettestad, Peter Hinderlie, Gwen Phung, James Lim, Jeff Miller
Published 2020-11-01

NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo

by Daniel A. Vallera, Soldano Ferrone, Behiye Kodal, Peter Hinderlie, Laura Bendzick, Brianna Ettestad, Caroline Hallstrom, Nicholas A. Zorko, Arpit Rao, Naomi Fujioka, Charles J. Ryan, Melissa A. Geller, Jeffrey S. Miller, Martin Felices
Published 2020-09-01